OPEN Health Appoints David Sakadelis as Chief Technology Officer
February 5, 2025 |
OPEN Health is pleased to announce the appointment of David Sakadelis as Chief Technology Officer. In this role, David will be responsible for enhancing our services through technology-enabled solutions for biopharma partners, focusing on solving challenges and driving innovation in our Solution Innovation Center.
February 5, 2025, London, UK – OPEN Health is pleased to announce the appointment of David Sakadelis as Chief Technology Officer. In this role, David will be responsible for enhancing our services through technology-enabled solutions for biopharma partners, focusing on solving challenges and driving innovation in our Solution Innovation Center.
OPEN Health’s Solution Innovation Center (SIC) consists of a cross-functional team that leverages technology partnerships to combine scientific expertise and proprietary product development to advance biopharmaceutical innovation in Medical Affairs and market access.
An experienced executive with over 25 years of expertise, including 13 years in biopharma with Publicis Health and Klick Health, David has led a wide range of projects. Notably, he spearheaded the development of connected patient services using innovative tools that address patient adherence and enhance patient-doctor communication. This suite of services has been recognized as a significant advancement for biopharma in patient engagement and stands as a testament to David’s ability to effectively apply technology to addressing healthcare needs.
In addition to his work on connected patient services, David has led the strategy and technical implementation for transformative content production that revolutionized the way high-volume content is produced by incorporating AI and automation, significantly reducing production costs and improving efficiency. He has also played a critical role in developing platforms designed to enhance engagement at medical congresses through real-time insights and personalized experiences.
“David’s strategic vision, technical acumen, and passion for leveraging technology to solve complex business challenges make him an ideal fit for OPEN Health,” said Steve Duryee, Chief Operating and Transformation Officer of OPEN Health. “We are excited to have him on board as he brings his expertise in IT, healthcare experience, and growth strategy to drive transformational change.”
“I am excited to join OPEN Health at such a pivotal moment, where technology and innovation are key to advancing biopharmaceutical companies,” said David. “I look forward to working with the talented team here to create impactful, technology-driven tools that address some of the most pressing challenges in Medical Affairs and market access. Together, we will continue to push the boundaries of what’s possible, delivering tangible value for our biopharma partners and improving patient outcomes globally.”
About OPEN Health
OPEN Health unites deep scientific knowledge with wide-ranging specialist expertise to unlock possibilities that improve health outcomes and patient well-being. Working in partnership with our clients, we embrace our different perspectives and strengths to deliver fresh thinking and solutions that make a difference. OPEN Health is a flexible global organization that solves complex healthcare challenges across consulting, HEOR and market access, scientific communications, patient engagement, and creative omnichannel communications. To learn more, visit www.openhealthgroup.com
Contact:
Candice Subero, VP of Global Marketing
This content was provided by OPEN Health
Company Details
Latest Content from OPEN Health
OPEN Health attend EB World Congress—building on momentum and strength in numbers for epidermolysis bullosa
Ben Speller shares his thoughts on the value of disease specific congresses
OPEN Health use PR to support clinical trial recruitment
International Clinical Trials Day finds clinical research in the spotlight like never before, with any news coming from the many studies into potential vaccines and treatments for SARS-CoV-2
OPEN Health | European Congress on Rare Diseases (ECRD) 2020 in 60 seconds
Gavin Jones, Director or Rare Disease, attends the congress to better understand the viewpoints of patient groups, health systems and payers
OPEN Health attend day 2 of the ECRD2020 congress
Gavin Jones is looking forward to sessions on innovation in advanced therapies and working towards equitable access.
OPEN Health continued support for My Name’5 Doddie
Charity fundraising for Motor Neuron Disease
OPEN Health’s latest partnership with Rare Revolution Magazine
Richard Jones introduces our Head of Health Psychology (Dr Sumira Riaz)
OPEN Health CSR Report 2019
Margot Hannah, Partner and Group Managing Director, and CSR lead at OPEN Health shares her thoughts on our latest report.
OPEN Health at ECRD 2020
Gavin Jones shares his thoughts on why congress is so important at this time and the key sessions he is looking forward to.
OPEN Health discuss Global Community in Rare Disease
Annie Rankin how we can work smarter with healthcare professionals
OPEN Health Patient & Brand Communications highly commended finalist
Shortlisted for Best Patient-Centric Approach for 2020 BOBI Awards.